T1	Participants 790 958	CONCLUSION For this population of low-risk patients, there was no significant difference in outcome after applications of a single intraoperative dose of beta radiation
T2	Participants 460 501	RESULTS Mean follow-up time was 24 months
T3	Participants 268 458	METHODS A prospective randomized trial of 65 eyes was designed, with 31 eyes receiving 750 rads of intraoperative beta radiation (group 1), and 34 eyes receiving no supplementation (group 2)
T4	Participants 58 266	PURPOSE To assess a single dose of intraoperative beta radiation used to enhance the success rate of trabeculectomy in a population of low-risk glaucoma patients in whom antimetabolites might not be indicated
